Subscribe To
Curevac begins phase 1 clinical trial for new covid-19 vaccine
Shares of CureVac CVAC, +0.47% were up 1.2% in premarket trading on Wednesday after the company said it dosed the first participant in a Phase 1 clini...
March 30, 2022, 7:54 am
Biovaxys technology to expand cancer vaccine platform with investigator-sponsored trial of colorectal cancer therapy
BioVaxys Technology Corp. (CSE:BIOV, OTCQB:BVAXF) plans to advance an Investigator-Sponsored Clinical Trial Application(CTA) for BVX-0922, its autolog...
March 30, 2022, 7:47 am
Dow jones newswires: biontech reports soaring earnings, revenue on covid vaccine, plans $1.5 billion in buybacks
German pharmaceutical company BioNTech SE reported soaring earnings and revenue for the fourth quarter, driven by the Covid-19 v...
March 30, 2022, 6:43 am
Novavax stock is a bet on interest from unvaccinated people
NVAX stock represents a vaccine that lacks approval. There is real appeal behind the narrative, as it m...
March 30, 2022, 6:23 am
Investors seek second act with moderna stock
Moderna hopes its combination vaccine for COVID and the flu can keep profits high but investors are ske...
March 29, 2022, 7:20 pm
Why moderna and biontech were winners today
The FDA expands its authorization for both companies' coronavirus vaccines....
March 29, 2022, 6:07 pm
Coronavirus: fda authorizes fourth covid shots from moderna and pfizer
Yahoo Finance's Anjalee Khemlani details the latest COVID vaccines for various age groups authorized by...
March 29, 2022, 5:20 pm
Here's why moderna shares are rising
Moderna Inc (NASDAQ: MRNA) shares are trading higher by 4.67% at $181.16 after the company received FDA approval for Emergency Use Authorization for a...
March 29, 2022, 3:29 pm
Cdc advises to mix j&j covid vaccine with pfizer or moderna booster
Data show that following up Johnson & Johnson's vaccine with a booster of an mRNA v...
March 29, 2022, 1:53 pm
Fda authorizes fourth dose of moderna, pfizer/biontech covid-19 vaccines for older people
The FDA has approved a second round of the Moderna Inc (NASDAQ: MRNA) or Pfizer Inc (NYSE: PFE), and BioNTech SE (NASDAQ: BNTX) COVID-19 v
March 29, 2022, 1:22 pm
Fda authorizes fourth covid vaccine dose for people age 50 and older
The U.S. Food and Drug Administration has authorized another Covid-19 vaccine dose from Pfizer and Mode...
March 29, 2022, 11:36 am
Second booster dose of pfizer, moderna covid-19 vaccines authorized by fda
The Food and Drug Administration (FDA) on Tuesday authorized another COVID-19 booster shot for people ages 50 and older....
March 29, 2022, 10:56 am
Fda authorizes fourth pfizer covid vaccine dose for people age 50 and older
The FDA made the decision comes without consulting its committee of independent vaccine experts....
March 29, 2022, 10:38 am
Moderna could have a big problem on its hands
The not-so-great side effects of Moderna's flu vaccine candidate could have greater implications....
March 29, 2022, 5:56 am
Healthcare group sanofi targets dupixent peak sales of over 13 billion euros
French healthcare group Sanofi, which lagged rivals in the race for COVID-19 vaccines, raised on Tuesda...
March 29, 2022, 12:58 am
Is moderna a better buy compared to pfizer?
Moderna Inc. (NASDAQ:MRNA) and Pfizer Inc. (NYSE:PFE) has been highly popular stocks since the outbreak of COVID-19. Their development of v...
March 28, 2022, 7:34 pm
Provention bio's coxsackievirus vaccine candidate elicits durable virus-neutralizing antibodies at six months
Provention Bio Inc (NASDAQ: PRVB) announced results from the final analysis of its first-in-human PROVENT study of PRV-101, a polyvalent inactivate...
March 28, 2022, 3:32 pm
Week in review: nuance in-licenses rsv vaccine in $225 million deal
Shanghai Nuance Pharma in-licensed China and Southeast Asia rights to a respiratory syncytial virus (RSV) vacc...
March 27, 2022, 9:23 am
Moderna, inc. (mrna) ceo stephane bancel presents on third annual vaccines day conference (transcript)
Moderna, Inc. (MRNA) CEO Stephane Bancel Presents on Third Annual Vaccines Day Conference (Transcript)...
March 25, 2022, 6:23 pm
Phibro (pahc) rises 6.1% since q2 earnings: what's driving it?
Investors are optimistic about Phibro's (PAHC) booming vaccine business and strong global presence....
March 25, 2022, 1:33 pm